Form 4: Immunocore Holdings Director Acquires Share Options

Director Siddharth Kaul acquired 14,534 share options in Immunocore Holdings plc on May 23, 2024, at an exercise price of $50.47.

Summary

• Siddharth Kaul, a director of Immunocore Holdings plc, acquired 14,534 share options on May 23, 2024.
• The exercise price for these options is $50.47.
• The options vest on the earlier of May 23, 2025, or the day before the next annual general meeting, contingent upon continuous service.
• The expiration date for the options is May 22, 2034.
• Following the transaction, Kaul directly owns 14,534 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a director acquiring share options, which can be seen as a slightly positive sign of confidence, but it's not a major event.

Positives

• A director's acquisition of share options can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, engages in a transaction involving the company's securities. It provides transparency to the market regarding insider activity.

Stakeholder Impact

• The acquisition of share options by a director could have a minor positive impact on shareholder sentiment.

Key Dates